Celldex Therapeutics, Inc. (CLDX) DCF Valuation

Celldex Therapeutics, Inc. (CLDX) DCF Valuation
  • Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • Pré-Construídos Para Uso Rápido E Eficiente
  • Não É Necessária Experiência; Fácil De Seguir

Celldex Therapeutics, Inc. (CLDX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Whether you’re an investor or analyst, this (CLDX) DCF Calculator is your go-to resource for accurate valuation. Equipped with real data from Celldex Therapeutics, Inc., you can adjust forecasts and observe the effects in real time.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019
AY2
2020
AY3
2021
AY4
2022
AY5
2023
FY1
2024
FY2
2025
FY3
2026
FY4
2027
FY5
2028
Revenue 3.6 7.4 4.7 2.4 6.9 8.8 11.3 14.6 18.7 24.0
Revenue Growth, % 0 107.61 -37.3 -49.32 192.02 28.34 28.34 28.34 28.34 28.34
EBITDA -49.7 -45.6 -66.1 -104.2 -139.0 -8.8 -11.3 -14.6 -18.7 -24.0
EBITDA, % -1390.06 -615.3 -1420.77 -4420.87 -2019.96 -100 -100 -100 -100 -100
Depreciation 4.9 2.0 3.1 1.4 3.0 5.2 6.7 8.6 11.1 14.2
Depreciation, % 135.96 26.96 65.96 59.4 43.7 59.21 59.21 59.21 59.21 59.21
EBIT -54.5 -47.6 -69.1 -105.6 -142.0 -8.8 -11.3 -14.6 -18.7 -24.0
EBIT, % -1526.03 -642.26 -1486.73 -4480.27 -2063.66 -100 -100 -100 -100 -100
Total Cash 64.4 194.4 408.3 305.0 423.6 8.8 11.3 14.6 18.7 24.0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 1.0 1.8 .2 .3 2.6
Account Receivables, % 28.41 24.29 3.7 14.72 38.18
Inventories -1.0 -1.8 -.2 -.3 .0 -1.3 -1.6 -2.1 -2.7 -3.4
Inventories, % -28.41 -24.29 -3.7 -14.72 0 -14.22 -14.22 -14.22 -14.22 -14.22
Accounts Payable 1.2 1.0 1.2 3.3 3.5 4.0 5.1 6.5 8.4 10.7
Accounts Payable, % 32.86 14.13 26.4 141.71 50.76 44.83 44.83 44.83 44.83 44.83
Capital Expenditure -.7 -1.6 -1.2 -1.8 -1.8 -3.0 -3.9 -5.0 -6.4 -8.3
Capital Expenditure, % -20.46 -20.92 -26.85 -77.56 -26.41 -34.44 -34.44 -34.44 -34.44 -34.44
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -54.0 -46.7 -68.9 -115.4 -142.0 -8.8 -11.3 -14.5 -18.6 -23.8
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -48.7 -46.4 -66.9 -113.7 -143.3 -4.2 -7.5 -9.7 -12.4 -15.9
WACC, % 11.96 11.96 11.96 11.96 11.96 11.96 11.96 11.96 11.96 11.96
PV UFCF
SUM PV UFCF -33.5
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -16
Terminal Value -163
Present Terminal Value -93
Enterprise Value -126
Net Debt -32
Equity Value -94
Diluted Shares Outstanding, MM 48
Equity Value Per Share -1.94

What You Will Get

  • Real Celldex Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Celldex Therapeutics, Inc. (CLDX).
  • Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates specific to Celldex.
  • Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Celldex’s fair value.
  • Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections for Celldex Therapeutics, Inc. (CLDX).
  • Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility in your analysis of Celldex.

Key Features

  • Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Celldex Therapeutics, Inc. (CLDX).
  • WACC Calculator: Pre-configured Weighted Average Cost of Capital sheet with adjustable inputs specific to the biotech sector.
  • Customizable Forecast Assumptions: Adjust growth projections, capital investments, and discount rates to fit your analysis.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios for Celldex Therapeutics, Inc. (CLDX).
  • Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for streamlined analysis.

How It Works

  • 1. Access the Template: Download and open the Excel file featuring Celldex Therapeutics, Inc. (CLDX) preloaded data.
  • 2. Adjust Assumptions: Modify key inputs such as growth rates, WACC, and capital expenditures tailored to Celldex Therapeutics, Inc. (CLDX).
  • 3. View Results Instantly: The DCF model automatically calculates the intrinsic value and NPV for Celldex Therapeutics, Inc. (CLDX).
  • 4. Explore Scenarios: Analyze various forecasts to evaluate different valuation outcomes for Celldex Therapeutics, Inc. (CLDX).
  • 5. Present with Confidence: Share professional valuation insights to bolster your decision-making regarding Celldex Therapeutics, Inc. (CLDX).

Why Choose Celldex Therapeutics, Inc. (CLDX) Calculator?

  • All-in-One Solution: Features DCF, WACC, and financial ratio analyses tailored for biotech investments.
  • Flexible Inputs: Modify highlighted cells to explore different investment scenarios.
  • In-Depth Analysis: Automatically computes Celldex’s intrinsic value and Net Present Value.
  • Preloaded Information: Access to historical and projected data for reliable assessments.
  • Expert-Level Tool: Perfect for financial analysts, investors, and healthcare consultants.

Who Should Use This Product?

  • Biotech Students: Explore drug development processes and apply theoretical knowledge to real-world scenarios.
  • Researchers: Integrate advanced models into your studies on immunotherapy and cancer treatments.
  • Investors: Evaluate your investment strategies and analyze the market performance of Celldex Therapeutics, Inc. (CLDX).
  • Market Analysts: Enhance your analysis with a customizable model tailored for biotech companies.
  • Healthcare Entrepreneurs: Understand the valuation methods used for emerging biotech firms like Celldex Therapeutics, Inc. (CLDX).

What the Template Contains

  • Pre-Filled DCF Model: Celldex Therapeutics’ financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Celldex’s profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.